SRPT
Sarepta Therapeutics, Inc. · Healthcare
Principal Financial Officer Joseph Bratica sold $184K of Sarepta Therapeutics, Inc.
Sold$183,975
$165.00Price
1,115Shares
−12%Stake
What SRPT did after the filing
- The stock from Mon, Dec 14 close, $169.54
- −46.8%
- S&P 500, same days
- +4.0%
Measured over 30 trading days, to the Jan 28 close.
Traded Fri, Dec 11. Filed Mon, Dec 14, 3:00 PM ET, during the session. Returns use the Dec 14 close and the Jan 28 close. Not investment advice.